I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant..:
de Gramont, Aimery
;
Van Cutsem, Eric
;
Schmoll, Hans-Joachim
...
The Lancet Oncology, Vol.13 No.12, pp.1225-1233. , 2021
Link:
https://hdl.handle.net/10371/177173
RT Journal T1
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial
UL https://suche.suub.uni-bremen.de/peid=base-ftseoulnuniv:oai:s-space.snu.ac.kr:10371_177173&Exemplar=1&LAN=DE A1 de Gramont, Aimery A1 Van Cutsem, Eric A1 Schmoll, Hans-Joachim A1 Tabernero, Josep A1 Clarke, Stephen A1 Moore, Malcolm J A1 Cunningham, David A1 Cartwright, Thomas H A1 Hecht, J. Randolph A1 Rivera, Fernando A1 Im, Seock-Ah A1 Bodoky, Gyoergy A1 Salazar, Ramon A1 Maindrault-Goebel, Frederique A1 Shacham-Shmueli, Einat A1 Bajetta, Emilio A1 Makrutzki, Martina A1 Shang, Aijing A1 Andre, Thierry A1 Hoff, Paulo M PB The Lancet Publishing Group YR 2021 K1 METASTATIC COLORECTAL-CANCER K1 STAGE-II K1 ANTIANGIOGENIC THERAPY K1 1ST-LINE TREATMENT K1 MONTHLY REGIMEN K1 FLUOROURACIL K1 LEUCOVORIN K1 IRINOTECAN K1 RESISTANCE K1 CARCINOMA JF The Lancet Oncology, Vol.13 No.12, pp.1225-1233 LK http://dx.doi.org/https://hdl.handle.net/10371/177173 DO https://hdl.handle.net/10371/177173 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)